Dr. John A. Chabot

Surgical Oncologist

Dr. Chabot is the Executive Director of the Pancreas Center and Chief of the Division of GI/Endocrine Surgery at Columbia University Medical Center. He earned his medical degree from Dartmouth Medical School and completed his residency at Columbia-Presbyterian Medical Center. Board-certified in Surgery, Dr. Chabot is a dedicated educator and researcher, contributing to advances in surgical oncology.

Education

  • Medical School: Dartmouth Medical School
  • Residency: General Surgery at Columbia-Presbyterian Medical Center
  • Board Certification: Surgery

Awards

  • Oliver Cope Meritorious Achievement Award from the American College of Surgeons
  • New York Super Doctors
  • America’s Top Doctors by Castle Connolly

Professional Memberships and Affiliation

  • Member of the American College of Surgeons
  • Member of the Society for Surgery of the Alimentary Tract
  • Executive Director of the Pancreas Center at Columbia

Clinical Experience

Dr. John A. Chabot has over 30 years of experience in complex gastrointestinal surgeries, including those for stomach cancer. He is known for his expertise in minimally invasive and robotic surgical techniques, which have enhanced patient recovery and outcomes. Dr. Chabot has also been instrumental in developing multidisciplinary approaches to cancer treatment.

Research and Publications

  • “Surgical management of gastric cancer: A 30-year experience” Annals of Surgery
  • “Enhanced recovery protocols after gastric surgery” Journal of Gastrointestinal Surgery
  • “Multidisciplinary approach to gastric cancer treatment” Surgical Clinics

Dr. John A. Chabot

Surgical Oncologist

Dr. Chabot is the Executive Director of the Pancreas Center and Chief of the Division of GI/Endocrine Surgery at Columbia University Medical Center. He earned his medical degree from Dartmouth Medical School and completed his residency at Columbia-Presbyterian Medical Center. Board-certified in Surgery, Dr. Chabot is a dedicated educator and researcher, contributing to advances in surgical oncology.